Semax vs Selank: Research Mechanisms, Evidence and Key Differences
Semax and Selank are both short synthetic regulatory peptides, and they are often grouped together because much of their published literature comes from neurochemical and central-nervous-system research. They are not the same peptide, however, and the evidence base for each points to overlapping but distinct research questions.
This guide compares their published mechanisms and evidence without treating either compound as an approved medicine or making therapeutic recommendations. Both products are supplied by Peps In Bulk strictly for research purposes.
Semax vs Selank at a Glance
| Feature | Semax | Selank |
|---|---|---|
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Common research themes | Neurotrophic signaling, BDNF, memory-related pathways, neuroprotection | GABA-related signaling, anxiety-related models, enkephalin metabolism |
| Shared research theme | Both have been studied for effects on enkephalin-degrading enzymes and brain functional connectivity. | |
| Evidence base | A mixture of in-vitro, animal and relatively small human studies; the evidence should not be treated as equivalent to large modern clinical-development programs. | |
What Research Has Studied About Semax
Semax is an ACTH-derived heptapeptide. Experimental work has examined neurotrophic signaling and brain-derived neurotrophic factor (BDNF). A rat study reported specific Semax binding in basal forebrain membranes and an increase in BDNF protein after intranasal administration. Other experimental work has examined BDNF and TrkB expression in rat hippocampus.
Separate laboratory research has investigated Semax in metal-binding and amyloid models, including its interaction with copper ions and amyloid-beta aggregation. These findings are mechanistic and experimental; they do not establish a clinical indication.
What Research Has Studied About Selank
Selank has been investigated in relation to GABAergic and anxiety-related pathways. A molecular study reported changes in radioligand GABA binding consistent with positive allosteric modulation in the experimental system used. Earlier work also reported inhibition of enkephalin-degrading enzymes.
Small human studies exist, including older work in anxiety-related populations, but their design, geography and scale differ substantially from contemporary large multicentre drug-development trials. They should therefore be interpreted cautiously.
Research Areas That Overlap
One useful comparison is that both peptides have been studied in the same experimental framework. A biochemical study found that both Semax and Selank inhibited enkephalin-degrading enzymes in human serum. A later functional-connectivity study examined Semax and Selank in 52 healthy participants and reported both shared and peptide-specific changes in connectivity involving the amygdala and temporal cortex.
That overlap does not mean the peptides are interchangeable. It shows that some research questions have been applied to both compounds while other mechanistic work has focused more strongly on one peptide than the other.
Evidence Limitations
- Much of the mechanistic literature is preclinical or based on relatively small samples.
- Different studies use different routes, models and endpoints, which limits direct comparison.
- Published findings about receptor binding, BDNF, connectivity or enzyme inhibition do not by themselves establish clinical effectiveness.
- Commercial peptide naming and purity should always be checked against the actual product information and supporting documentation available for the batch.
Semax and Selank Product Formats
Peps In Bulk lists both Semax and Selank as research products in 10-vial pack formats. Current strength options, AUD pricing and any available product documentation are shown on the individual product pages. You can also browse the wider nootropics and wellness research category.
Selected Published References
- Semax and Selank inhibition of enkephalin-degrading enzymes in human serum.
- Semax binding and BDNF findings in rat basal forebrain.
- Review of molecular aspects of Selank biological activity.
- Functional-connectivity study comparing Selank and Semax.
Research information only. This article does not provide medical, therapeutic or dosing advice.